Empresa Haleon plc

Empresa Haleon plc

HLN

GB00BMX86B70

Farmacéuticos

Consenso de los analistas

Acciones

HLN

GB00BMX86B70

Farmacéuticos

Consenso de los analistas

Resumen de negocios

Ventas por actividad

Ventas por región

Directores

Administradores

Clase de acciones

Accionistas

Información de la empresa

Empresas del grupo

Sector

Ventas por actividad

Ventas por región

Notaciones para Haleon plc

Revisiones del BPA

Beneficios trimestrales - Tasa de sorpresa

Sector Farmacéuticos - Otros

Resumen de negocios

Ventas por actividad

Ventas por región

Directores

Administradores

Clase de acciones

Accionistas

Información de la empresa

Empresas del grupo

Sector

Ventas por actividad

Ventas por región

Notaciones para Haleon plc

Revisiones del BPA

Beneficios trimestrales - Tasa de sorpresa

Sector Farmacéuticos - Otros

Mercado cerrado - London S.E. Otros sitios de cotización 17:35:01 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
334,4 ^GBX	+0,87 %		+2,64 %	+3,96 %

25/04	Moody's afirma la calificación de Haleon gracias a sus sólidos resultados operativos	MT
24/04	Haleon nombra a la jefa de finanzas de Tate & Lyle directora financiera a partir de noviembre	AN

Haleon plc está especializada en la investigación, fabricación y comercialización de medicamentos y productos farmacéuticos de consumo. Las ventas netas se desglosan por familias de productos de la siguiente manera:
- productos para la salud bucal (27,7%; nº 1 mundial): Sensodyne, Parodontax, Polident, Biotene, marcas Aquafresh, etc;
- Medicamentos para aliviar el dolor (23,5%; nº 1 mundial): Panadol, Advil, Voltaren, marcas Excedrin, etc;
- Medicamentos para la salud digestiva (18,9%; nº 1 mundial): TUMS, Nicorette, ENO, Chap Stick, Fenistil, marcas Nexium, etc;
- medicamentos respiratorios (15,4%; nº 1 mundial): Theraflu, Otrivin, Flonase, marcas Contac, etc;
- vitaminas, minerales y complementos alimenticios (14,5%; nº 1 mundial): Marcas Centrum, Emergen-C, Caltrate, etc.
Las ventas netas se distribuyen geográficamente de la siguiente manera: Europa/Oriente Medio/África/América Latina (40,2%), América del Norte (37,1%) y Asia/Pacífico (22,7%).

Número de empleados: 25 408

GBP en millones	2022	Peso	2023	Peso	Delta
Oral Health 27,7 %	2 957	27,2 %	3 136	27,7 %	+6,05 %
Pain Relief 23,5 %	2 551	23,5 %	2 652	23,5 %	+3,96 %
Digestive Health and Other 18,9 %	2 096	19,3 %	2 138	18,9 %	+2,00 %
Respiratory Health 15,4 %	1 579	14,5 %	1 736	15,4 %	+9,94 %
Vitamins, Minerals and Supplements 14,5 %	1 675	15,4 %	1 640	14,5 %	-2,09 %

GBP en millones	2022	Peso	2023	Peso	Delta
EMEA and Latin America 40,2 %	4 270	39,3 %	4 545	40,2 %	+6,44 %
North America 37,1 %	4 116	37,9 %	4 195	37,1 %	+1,92 %
APAC 22,7 %	2 472	22,8 %	2 562	22,7 %	+3,64 %

Directores	Puesto	Edad	Desde
Brian McNamara CEO	Chief Executive Officer	57	22/07/21
Tobias Hestler DFI	Director of Finance/CFO	52	01/12/21
Franck Riot CTO	Chief Tech/Sci/R&D Officer	-	16/12/21
Sonya Ghobrial IRC	Investor Relations Contact	-	-
Tamara Rogers SAM	Sales & Marketing	-	16/12/21
Lisa Paley PRN	Corporate Officer/Principal	-	-
Keith Choy PRN	Corporate Officer/Principal	-	-
Filippo Lanzi PRN	Corporate Officer/Principal	-	-
Mairéad Nayager HRO	Human Resources Officer	-	01/03/22
Bjarne Tellmann LAW	General Counsel	57	16/12/21

Administradores	Puesto	Edad	Desde
Bryan Supran BRD	Director/Board Member	-	18/07/22
Dame Cox BRD	Director/Board Member	63	18/07/22
Tracy Clarke BRD	Director/Board Member	57	18/07/22
Vindi Banga BRD	Director/Board Member	69	18/07/22
Deirdre Mahlan BRD	Director/Board Member	61	18/07/22
David Lewis CHM	Chairman	59	23/05/22
David Denton BRD	Director/Board Member	59	01/03/23
Tobias Hestler DFI	Director of Finance/CFO	52	01/12/21
Brian McNamara CEO	Chief Executive Officer	57	22/07/21
Asmita Dubey BRD	Director/Board Member	-	18/07/22

	Vote	Quantity	Flotante	Autocontrol	Total Float
Acción A	1	9 132 301 104	7 072 820 336 ( 77,45 %)	0	77,45 %

Nombre	Acciones	%	Valoración
PFIZER, INC. 32,36 %	2 955 063 626	32,36 %	12 435 M p
GSK PLC 4,219 %	385 320 110	4,219 %	1 621 M p
The Vanguard Group, Inc. 1,790 %	163 500 000	1,790 %	688 M p
Dodge & Cox 1,733 %	158 253 000	1,733 %	666 M p
Norges Bank Investment Management 1,621 %	148 004 000	1,621 %	623 M p
MFS International (UK) Ltd. 1,379 %	125 915 466	1,379 %	530 M p
GIC Pte Ltd. (Investment Management) 1,045 %	95 442 000	1,045 %	402 M p
BlackRock Advisors (UK) Ltd. 0,9963 %	90 981 000	0,9963 %	383 M p
BlackRock Investment Management (UK) Ltd. 0,7176 %	65 536 000	0,7176 %	276 M p
Royal London Asset Management Ltd. 0,5687 %	51 936 000	0,5687 %	219 M p

Nombre	Acciones	%	Valoración
Dodge & Cox 2,424 %	110 663 098	2,424 %	940 M p
Fidelity Management & Research Co. LLC 1,399 %	63 897 244	1,399 %	542 M p
ClearBridge Investments LLC 0,5822 %	26 581 902	0,5822 %	226 M p
Harding Loevner LP 0,4900 %	22 372 190	0,4900 %	190 M p
Fisher Asset Management LLC 0,3228 %	14 737 776	0,3228 %	125 M p
Wellington Management Co. LLP 0,2966 %	13 542 346	0,2966 %	115 M p
AllianceBernstein LP 0,2396 %	10 939 898	0,2396 %	93 M p
Aristotle Capital Management LLC 0,1950 %	8 905 038	0,1950 %	76 M p
Merrill Lynch International 0,1843 %	8 414 511	0,1843 %	71 M p
Douglas Lane & Associates LLC 0,1840 %	8 401 876	0,1840 %	71 M p

Haleon Plc

The Heights Building 5, 1st Floor

KT13 0NY, Weybridge

+44 1932 822000

http://www.haleon.com

Nombre	Categoría y sector
GlaxoSmithKline Consumer Pvt Ltd. GlaxoSmithKline Consumer Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Consumer Pvt Ltd. is an Indian company that develops, manufactures, and distributes vaccines and other pharmaceutical products. The private company is based in Patiala, India and was founded in 2014.	Pharmaceuticals: Major
GlaxoSmithKline Consumer Healthcare Finance Ltd. GlaxoSmithKline Consumer Healthcare Finance Ltd. Financial ConglomeratesFinance Founded in 2014, GlaxoSmithKline Consumer Healthcare Finance Ltd. is a British company that provides investment services. Part of GSK Plc, the private company is based in Brentford, UK.	Financial Conglomerates
GlaxoSmithKline Consumer Healthcare Holdings Ltd. GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The private company is based in Brentford, UK.	Financial Conglomerates
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. is a British company that offers Voltarol patches and plasters for effective pain relief. The private company is based in Brentford, UK. The text from the 'description' mentions that Voltarol offers different kinds of patches and plasters for pain relief and provides information on common causes of foot and ankle pain. The company was founded in 2014.	Financial Conglomerates
Haleon UK Trading Services Ltd. Haleon UK Trading Services Ltd. Drugstore ChainsRetail Trade Part of Haleon Uk Holdings (No. 3) Ltd., Haleon UK Trading Services Ltd. is a wholesaler of pharmaceutical goods. The private company is based in Weybridge, UK. Founded in 2012.	Drugstore Chains
GSK Consumer Healthcare Capital US LLC GSK Consumer Healthcare Capital US LLC Medical/Nursing ServicesHealth Services Part of Haleon Plc, Haleon US Capital LLC is a private company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE.	Medical/Nursing Services
Haleon UK Capital Plc Haleon UK Capital Plc Regional BanksFinance Part of Haleon Plc, Haleon UK Capital Plc is a financial intermediation company. Haleon UK Capital Plc is based in Middlesex, UK. The British company was founded in 2021. The CEO is Brian James McNamara.	Regional Banks
Gsk Consumer Healthcare Capital Nl BV Gsk Consumer Healthcare Capital Nl BV Pharmaceuticals: OtherHealth Technology Part of Haleon Plc, Haleon Netherlands Capital BV is a British company that manufactures medicinal and botanicals. The private company is located in the UK.	Pharmaceuticals: Other

Calificación trading

Calificación Inversor

ESG Refinitiv

Más Ratings

Venta

Compra

Recomendación promedio

ACUMULAR

Numero de análisis

Último precio de cierre

3,344 GBP

Precio objetivo promedio

3,594 GBP

Diferencia / Objetivo Promedio

+7,47 %

Consenso

Revisiones de las previsiones

La agenda de la empresa

	Varia. 1 de ene.	Capi.
HALEON PLC	+3,96 %	38,04 mil M
ELI LILLY AND COMPANY	+25,83 %	661 mil M
NOVO NORDISK A/S	+27,00 %	566 mil M
JOHNSON & JOHNSON	-6,76 %	352 mil M
MERCK & CO., INC.	+20,34 %	332 mil M
ABBVIE INC.	+3,00 %	283 mil M
ASTRAZENECA PLC	+13,09 %	231 mil M
NOVARTIS AG	+5,46 %	200 mil M
ROCHE HOLDING AG	-9,61 %	195 mil M
AMGEN INC.	-6,26 %	145 mil M

Farmacéuticos - Otros

Farmacéutica e investigación médica

Farmacéuticos

Farmacéuticos

Farmacéuticos - Otros